Meet the OBR Editorial Board

Editor's Note: At OBR we have created an editorial board of renown thought leaders in different cancer disease areas. The role of our editorial board is to provide valuable insights through editorial commentary accompanying our daily news. We call it virtual access. By providing our insights into the daily news, you will have access into how these thought leading oncologists interpret the oncology news and events we carry in OBR daily. We hope that our editorial boards's insights will bring great value to the oncology community.

View all Editorial Board Member Commentary

Browse Editors by Section

member-photo

Debu Tripathy, MD

Professor and Chair, Department of Breast Medical Oncology
The University of Texas MD Anderson Cancer Center

Comments

Update on PALLAS, an International Academic Breast Cancer Study Evaluating Adjuvant Palbociclib Second Interim Analysis of Adjuvant

quotesThe interim analysis of the very large PALLAS trial testing the addition of 2 years of palbociclib t…quotes

member-photo

Howard S. Hochster, MD

Distinguished Professor of Medicine, Rutgers Robert Wood Johnson Medical School
Rutgers-CINJ Associate Director, Clinical Research
Director Clinical Oncology Research, RWJ-B Health System

Comments

Merck and Eisai Receive Complete Response Letter for KEYTRUDA® (pembrolizumab) plus LENVIMA® (lenvatinib) Combination as First-Line Treatment for Unresectable Hepatocellular Carcinoma

quotesWhile a "complete response" is great for our patients, the Complete Response Letter was less auspici…quotes

member-photo

Ted Okon

Executive Director
Community Oncology Alliance

Comments

PBM Middlemen Continue to Dodge Responsibility for Patient Suffering and Rising Drug Prices

quotesPBMs are getting more brazen in how they delay and deny cancer patients their oral drugs. Anyone in …quotes

member-photo

William McGivney, PhD

National Health Policy Expert

Comments

Don’t Count on Lower Premiums Despite Pandemic-Driven Boon for Insurers

quotesIt is interesting to see "record profits" for managed care companies in the face of the Covid-19 Pan…quotes

member-photo

Tomasz M. Beer, MD, FACP

Professor of Medicine, Division of Hematology/Medical Oncology, School of Medicine
Grover C. Bagby Chair of Prostate Cancer Research
OHSU Knight Cancer Institute Deputy Director, OHSU Knight Cancer Institute, School of Medicine
Chief Medical Officer, CEDAR, OHSU Knight Cancer Institute, School of Medicine

Comments

FDA Approves Olaparib For HRR Gene-Mutated Metastatic Castration-Resistant Prostate Cancer

quotesPAPR inhibitor approval means that we will need to genotype all advanced prostate cancer patients. …quotes

member-photo

Tomasz M. Beer, MD, FACP

Professor of Medicine, Division of Hematology/Medical Oncology, School of Medicine
Grover C. Bagby Chair of Prostate Cancer Research
OHSU Knight Cancer Institute Deputy Director, OHSU Knight Cancer Institute, School of Medicine
Chief Medical Officer, CEDAR, OHSU Knight Cancer Institute, School of Medicine

Comments

FDA Approves Olaparib For HRR Gene-Mutated Metastatic Castration-Resistant Prostate Cancer

quotesPAPR inhibitor approval means that we will need to genotype all advanced prostate cancer patients. …quotes

member-photo

Dean Gesme, MD

FACP FACPE FASCO
President, Minnesota Oncology

Comments

Trump Expected To Sign Drug Pricing Executive Orders Friday, Angering Pharma

quotesTrump gave just Congress and manufacturers 30 days to develop and pass a Part B Medicare drug acquis…quotes

member-photo

Debu Tripathy, MD

Professor and Chair, Department of Breast Medical Oncology
The University of Texas MD Anderson Cancer Center

Comments

Update on PALLAS, an International Academic Breast Cancer Study Evaluating Adjuvant Palbociclib Second Interim Analysis of Adjuvant

quotesThe interim analysis of the very large PALLAS trial testing the addition of 2 years of palbociclib t…quotes

member-photo

H. Jack West, MD

Associate Clinical Professor, Medical Oncology
Executive Director, Employer Services
City of Hope Comprehensive Cancer Center
Duarte, CA

Comments

Sanofi And MD Anderson Announce Strategic Collaboration To Accelerate Oncology Research And Development

quotesUnclear to me why this doesn't raise alarm bells as a conflict of interest. Why is an institution ab…quotes

member-photo

Howard S. Hochster, MD

Distinguished Professor of Medicine, Rutgers Robert Wood Johnson Medical School
Rutgers-CINJ Associate Director, Clinical Research
Director Clinical Oncology Research, RWJ-B Health System

Comments

Merck and Eisai Receive Complete Response Letter for KEYTRUDA® (pembrolizumab) plus LENVIMA® (lenvatinib) Combination as First-Line Treatment for Unresectable Hepatocellular Carcinoma

quotesWhile a "complete response" is great for our patients, the Complete Response Letter was less auspici…quotes

member-photo

Howard Sandler, MD, MS, FASTRO

Ronald H. Bloom Chair in Cancer Therapeutics
Professor and Chair, Department of Radiation Oncology
Interim Director, Samuel Oschin Comprehensive Cancer Institute
Cedars-Sinai Medical Center

Comments

Radiotherapy Can Be Used In Hard-to-treat Bladder Cancer

quotesRadiotherapy as primary treatment (along with TUR and chemotherapy) is having a bit of a renaissance…quotes

member-photo

Robert A. Figlin, MD., FACP

Steven Spielberg Family Chair in Hematology Oncology
Professor of Medicine and Biomedical Sciences
Deputy Director, Cedars-Sinai Cancer
Deputy Director, Samuel Oschin Comprehensive Cancer Institute
Cedars-Sinai Medical Center

Comments

CT Scans Can Reduce Lung Cancer Deaths, Study Finds

quotesThis long awaited trial performed by the National Cancer Institute demonstrates the benefits of low …quotes

member-photo

Stephen M. Schleicher, M.D., MBA

Community Oncology,
Medical Oncologist,
OneOncology

No comments to show!

member-photo

Ted Okon

Executive Director
Community Oncology Alliance

Comments

PBM Middlemen Continue to Dodge Responsibility for Patient Suffering and Rising Drug Prices

quotesPBMs are getting more brazen in how they delay and deny cancer patients their oral drugs. Anyone in …quotes

member-photo

Thomas Marsland, MD

Vice President
Integrated Community Oncology Network
Former Community Representative
ASCO Board of Directors

Comments

Opinion: Pandemic Makes Expanding Medicaid Even More Vital For Cancer Patients

quotesI actually enjoyed the experience. I certainly missed mingling with friends and colleagues. Also mis…quotes

member-photo

William McGivney, PhD

National Health Policy Expert

Comments

Don’t Count on Lower Premiums Despite Pandemic-Driven Boon for Insurers

quotesIt is interesting to see "record profits" for managed care companies in the face of the Covid-19 Pan…quotes

member-photo

H. Jack West, MD

Associate Clinical Professor, Medical Oncology
Executive Director, Employer Services
City of Hope Comprehensive Cancer Center
Duarte, CA

Comments

Sanofi And MD Anderson Announce Strategic Collaboration To Accelerate Oncology Research And Development

quotesUnclear to me why this doesn't raise alarm bells as a conflict of interest. Why is an institution ab…quotes

member-photo

Robert A. Figlin, MD., FACP

Steven Spielberg Family Chair in Hematology Oncology
Professor of Medicine and Biomedical Sciences
Deputy Director, Cedars-Sinai Cancer
Deputy Director, Samuel Oschin Comprehensive Cancer Institute
Cedars-Sinai Medical Center

Comments

CT Scans Can Reduce Lung Cancer Deaths, Study Finds

quotesThis long awaited trial performed by the National Cancer Institute demonstrates the benefits of low …quotes

member-photo

Dean Gesme, MD

FACP FACPE FASCO
President, Minnesota Oncology

Comments

Trump Expected To Sign Drug Pricing Executive Orders Friday, Angering Pharma

quotesTrump gave just Congress and manufacturers 30 days to develop and pass a Part B Medicare drug acquis…quotes

member-photo

Thomas Marsland, MD

Vice President
Integrated Community Oncology Network
Former Community Representative
ASCO Board of Directors

Comments

Opinion: Pandemic Makes Expanding Medicaid Even More Vital For Cancer Patients

quotesI actually enjoyed the experience. I certainly missed mingling with friends and colleagues. Also mis…quotes

member-photo

Howard Sandler, MD, MS, FASTRO

Ronald H. Bloom Chair in Cancer Therapeutics
Professor and Chair, Department of Radiation Oncology
Interim Director, Samuel Oschin Comprehensive Cancer Institute
Cedars-Sinai Medical Center

Comments

Radiotherapy Can Be Used In Hard-to-treat Bladder Cancer

quotesRadiotherapy as primary treatment (along with TUR and chemotherapy) is having a bit of a renaissance…quotes